A PHASE I STUDY OF HCW9218, A BIFUNCTIONAL TGFb ANTAGONIST/IL-15 PROTEIN COMPLEX, IN ADVANCED SOLID TUMORSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
Safety and activity of the IL-15/sIL-15Rα complex ALT-803 in combination with the anti-PD1 mAb nivolumab in metastatic non-small cell lung cancerCLINICAL CANCER RESEARCHIF10.22018-09-010PRE
Safety and activity of the IL-15/sIL-15Rα complex ALT-803 in combination with the anti-PD1 mAb nivolumab in metastatic non-small cell lung cancerCLINICAL CANCER RESEARCHIF10.22018-09-010PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向